Smaller sized doses for perioral treatment than for higher facial purposes are utilised as being the oral musculature responds much more strongly to the same BTX-A dosing. Only one preparation of botulinum toxin type B (MyoBloc®/NeuroBloc®) exists. Its sole indicator and FDA acceptance lies in treatments of cervical dystonia. https://jeffu481iqx3.blogars.com/profile